Back to Search
Start Over
SAA1 and metabolomic signatures predict hyperprogression with immunotherapy in pan cancers.
- Source :
-
Clinical and translational medicine [Clin Transl Med] 2024 Mar; Vol. 14 (3), pp. e1624. - Publication Year :
- 2024
- Subjects :
- Humans
Disease Progression
Immunotherapy
Serum Amyloid A Protein
Neoplasms therapy
Subjects
Details
- Language :
- English
- ISSN :
- 2001-1326
- Volume :
- 14
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Clinical and translational medicine
- Publication Type :
- Report
- Accession number :
- 38468504
- Full Text :
- https://doi.org/10.1002/ctm2.1624